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Abstract: 
SARS-CoV-2 pneumonia may induce an aberrant immune response with brisk recruitment of myeloid 
cells into the lower respiratory tract, which may contribute to morbidity and mortality. We describe 
endotracheal aspirate samples from seven patients with SARS-CoV-2 pneumonia requiring mechanical 
ventilation. We note SARS-CoV-2 virions within lower respiratory tract myeloid cells shown by electron 
tomography, immunofluorescence confocal imaging, and immuno-electron microscopy. Endotracheal aspirates 
are primarily composed of mononuclear and polymorphonuclear leukocytes. These myeloid cells that harbor 
virus are frequently positive for CD14 and/or CD16 and most display an inflammatory phenotype marked by 
expression of IL-6 and tissue factor mRNA transcript and protein expression. 
 
Brief Report: 
SARS-CoV-2 pneumonia may induce an aberrant immune response with brisk recruitment of myeloid 
cells into the airspaces.1–3 Although the clinical implications are unclear, others have suggested that infiltrating 
myeloid cells may contribute to morbidity and mortality during SARS-CoV-2 infection.1,4,5    
We examined endotracheal aspirates (Supplemental methods) from seven patients with severe COVID-
19 pneumonia who required mechanical ventilation (Table 1): three patients required extra-corporeal membrane 
oxygenation and two patients were deceased by 60 days of follow-up from intensive care unit admission. 
Endotracheal aspirates were primarily composed of mononuclear and polymorphonuclear leukocytes (Figure 
1A, range 70.6-97.5% of nucleated cells). Electron tomography (ET) of endotracheal aspirates revealed intra-
cellular localization of presumptive SARS-CoV-2 virions in mononuclear leukocytes (representative image, 
Figure 1B) and polymorphonuclear leukocytes (representative image, Figure 1C). The identification of SARS-
CoV-2 virions by ET was consistent with immune-electron microscopy using an antibody against the 
Nucleocapsid protein of SARS-CoV-2 that confirmed the presence of virus in CD14+ cells in the lower airways 
(representative image, Figure 1D). Quantitative imaging of ETA cells revealed SARS-CoV-2 Nucleocapsid 
protein expression (Figure 1E; n=6; Patient 7 did not have sufficient ETA available for imaging), many of 
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which were also positive for CD14 or CD16 immunostaining (Figure 1F; representative image displayed in 
Figure 1G).  Myeloid cells that expressed SARS-CoV-2 Nucleocapsid protein also frequently expressed IL-6 
and tissue factor protein (Figure 1H). Finally, we noted that endotracheal aspirate myeloid cells showed IL6, F3 
and CD14 transcripts (representative image, Figure 1I). 
Taken together, our findings suggest that myeloid cells found in endotracheal aspirate samples harbor 
SARS-CoV-2 and display an inflammatory phenotype marked by expression of IL-6 and tissue factor. The 
mechanisms by which virions enter lower respiratory tract myeloid cells and survive phagocytic degradation are 
unclear. However, others have noted human monocyte-derived macrophages to harbor SARS-CoV-1 virus 
without productive replication in vitro and prior reports have shown survival of HIV virions in bone marrow 
macrophages in a humanized mouse model.6,7 The clinical implications of our findings are unknown, but it is 
intriguing to consider that the purported benefits of dexamethasone in patients with SARS-CoV-2 pneumonia 
requiring mechanical ventilation8 may potentially result from modulation of inflammatory myeloid cells 
recruited to lung airspaces, which are deleterious in mouse models of SARS-CoV-1 pneumonia.9  Further work 
remains to determine the clinical implications of myeloid cells harboring SARS-CoV-2 virus during severe 
SARS-CoV-2 pneumonia. 
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Figure 1 
 
(A) Representative images of cytospins prepared from endotracheal aspirate (ETA) samples – Patient 3 is on 
the left and Patient 6 is on the right. Black arrowheads denote mononuclear cells and red arrowheads 
denote polymorphonuclear cells. Black scale bar in lower right portion of each image indicates 20 
microns. 
(B) Electron microscopy (EM) overview of lower respiratory tract mononuclear leukocyte (presumptive 
macrophage) from Patient 4 with upper inset demonstrating the region indicated by the square that 
shows tomographic slice with presumptive SARS-CoV-2 virion in a smooth-walled compartment or 
surface invagination. Lower inset shows higher magnification tomographic view of presumptive virion 
with apparent spike proteins indicated by red arrowheads. 
(C) Polymorphonuclear leukocyte (presumptive neutrophil) from Patient 7 with inset showing the region 
indicated by the square in the overview containing presumptive SARS-CoV-2 virions (red arrowheads).  
(D) ImmunoTEM of lower respiratory tract mononuclear leukocyte from Patient 6 with CD14 (18 nm gold 
colloid, open arrowhead) surface immunostaining and internal immunostaining of SARS-CoV-2 
Nucleocapsid protein (6 nm gold colloid, black arrowheads at clusters of staining)  
(E) Quantitative immunofluorescence with median percentage (n=3 slides per patient) of total ETA cells 
that expressed SARS-CoV-2 Nucleocapsid protein (n=6 patients, Patient 7 did not have sufficient 
endotracheal aspirate for immunofluorescence staining). 
(F) Percentage of endotracheal aspirate cells that co-expressed Nucleocapsid protein and CD14 or CD16 
(n=6 patients). 
(G) Representative montage from a single polymorphonuclear cell illustrating co-localization by 
immunofluorescence. Panels from left to right show: a) merge, b) CD14 (green), c) IL-6 (red), d) 
SARS-CoV-2 Nucleocapsid protein (white), and e) Imaris (Bitplane) surface rendered image of the 
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overlapping areas of labeling. The blue nuclear stain in all panels is DAPI. White scale bar is 10 
microns. 
(H) Quantitative immunofluorescence of Nucleocapsid protein positive cells that co-expressed IL-6 or tissue 
factor (TF) (n=6 patients).  
(I) Representative in situ localization of CD14 (green), IL6 (white), and tissue factor or F3 (red) transcript 
as well as DAPI nuclear staining (blue) in ETA myeloid cell.  
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Table 1: Clinical characteristics of seven patients with severe SARS-CoV-2 pneumonia 
Patient 
Age 
Range 
Gender Days from symptom onset to MV Days from MV to ETA sample 
1 60-69 M 3 2 
2 50-59 M 11 5 
3 50-59 M 7 1 
4 70-79 F 3 14 
5 70-79 F 7 2 
6 50-59 M 5 10 
7 50-59 M 9 6 
 
Abbreviations: ETA = endotracheal aspirate; F = female; M = male; MV = mechanical ventilation. 
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 Supplemental Methods 
Patients  
Samples were prospectively collected from patients hospitalized in intensive care units (ICU) at the 
University of Pittsburgh Medical Center Presbyterian and Shadyside hospitals with SARS-CoV-2 infection as 
documented by RT-PCR. Patients were enrolled within 72 hours of intubation whenever possible. Upon the 
informed consent of the patient’s legally authorized representative, patients were enrolled in the University of 
Pittsburgh Acute Lung Injury Registry and Biospecimen Repository (IRB# PRO10110387), which has been 
described elsewhere.10,11 Longitudinal samples were collected on days 5 and 10 after enrollment. 
 
Sample collection, handling, and virus inactivation 
Endotracheal aspirates were collected from mechanically ventilated patients after pre-oxygenation with 
100% oxygen for 2 minutes. 5-10 milliliters of 0.9% sodium chloride solution were instilled via the instillation 
port on the closed suction system of the endotracheal tube to lavage the airspaces. De-identified samples were 
placed in biohazard bags and decontaminated per local protocol then transported on ice for further processing in 
a Bio-Safety level 2+ laboratory space.12 Raw endotracheal aspirates were diluted 1:1 in 8% (volume/volume) 
paraformaldehyde and stored at 4°C overnight to inactivate virus. Following viral inactivation with 4% 
paraformaldehyde overnight fixation, endotracheal aspirates were washed twice in sterile phosphate buffered 
saline (PBS) and pelleted at 600 g. 
 
Electron tomography 
The washed cell pellet was re-suspended in 0.5 mL 1% glutaraldehyde then pelleted at 600 g and stored 
at 4°C. ETA samples were further centrifuged to concentrate the pellet, then transferred to brass planchettes 
(Ted Pella, Inc.) and ultra-rapidly frozen with a HPM-010 high pressure freezer (Bal-Tec/ABRA, Switzerland). 
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As previously described,6 the vitrified samples were transferred under liquid nitrogen to cryotubes (Nunc) 
containing a frozen solution of 2.5% osmium tetroxide, 0.05% uranyl acetate in acetone. Tubes were loaded into 
an AFS freeze-substitution machine (Leica Microsystems) and processed at -90°C for 72 hr, warmed over 12 hr 
to -20°C, held at that temperature for 8 hr, then warmed to 4°C for 1 hr. The fixative was removed and the 
samples rinsed 4 x with cold acetone, following which they were infiltrated with Epon-Araldite resin (Electron 
Microscopy Sciences, Port Washington, PA) over 48 hr. Samples were flat-embedded between two Teflon-
coated glass microscope slides and the resin polymerized at 60°C for 48 hr. Flat-embedded ETA was observed 
with a stereo dissecting microscope to ascertain and select well-preserved samples. Suitable regions were 
extracted with a scalpel and glued to the tips of plastic sectioning stubs. Semi-thick (300-400 nm) serial sections 
were cut with a UC6 ultramicrotome (Leica Micro-systems) using a diamond knife (Diatome, Ltd. Switzerland). 
Sections were placed on Formvar-coated copper-rhodium slot grids (Electron Microscopy Sciences) and stained 
with 3% uranyl acetate and lead citrate. Gold beads (10 nm) were placed on both surfaces of the grid to serve as 
fiducial markers for subsequent image alignment. Grids were placed in a dual-axis tomography holder (Model 
2040, E.A. Fischione Instruments, Export, PA) and imaged with a Tecnai TF30ST-FEG trans-mission electron 
microscope (300 KeV; ThermoFisher Scientific) equipped with a 2K CCD camera (XP1000; Gatan, Inc, 
Pleasanton CA). Tomographic tilt-series and large-area montaged over-views were acquired using the SerialEM 
software package (Mastronarde, 2005). For tomography, samples were tilted + /- 64° and images collected at 1° 
intervals. The grid was then rotated 90° and a similar series taken about the orthogonal axis. Tomographic data 
were calculated, analyzed and modeled using the IMOD software package (Kremer et al., 1996; Mastronarde, 
2008) on MacPro and iMac Pro computers (Apple, Inc, Cupertino, CA). 
 
Cytospin preparation and endotracheal aspirate cell differential 
Washed cell pellets were re-suspended in sterile PBS prior to spinning at 300 RPM in a Shandon 
Cytospin3 onto a Superfrost plus microscope slide (Fisher Scientific) then air dried. One cytospin slide was 
All rights reserved. No reuse allowed without permission. 
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 
The copyright holder for this preprintthis version posted August 14, 2020. ; https://doi.org/10.1101/2020.08.11.20171967doi: medRxiv preprint 
 
9 
 
stained with Diff-Quick (Siemens) then evaluated under light microscopy to confirm acceptable spacing and 
numbers of cells. Cell differentials were performed by manual counts of 200 nucleated cells by three separate 
authors who were blinded to the others’ results – the mean result of the counts was utilized. Representative 
images were obtained utilizing an Olympus Provis I fluorescence microscope.  
 
Immunofluorescence 
Cytospin slides were prepared as above then placed in 70% (vol/vol) ethyl alcohol followed by 90% 
(vol/vol) ethyl alcohol for 10 minutes each, then allowed to air dry. Slides were stored at -20°C for subsequent 
staining. To perform immunofluorescence staining, cells were washed 3 times in PBS, permeabilized in 0.1% 
Triton-X-100 in PBS for 20 min, and then washed once with PBS.  Cells were then blocked in 20% normal goat 
serum in PBS for 40 minutes then washed once with 0.5% BSA in PBS (BPBS).  Primary antibodies 
(Supplemental Table 1) were added to cells in BPBS at a 1:100 dilution and incubated the at room temperature 
for 1 hour. Cells were washed 4 times in BPBS then secondary antibodies at designated dilutions were added 
for 1 hour at room temperature.  Cells were washed 3 times in BPBS then 3 times in PBS. Nuclei were labeled 
with 0.1% Hoechst’s dye for 30 seconds then rinsed with PBS.  Cells were cover slipped using gelvatol (23 g 
poly(vinyl alcohol) 2000, 50 ml glycerol, 0.1% sodium azide to 100 ml PBS), then viewed on a confocal 
scanning fluorescence microscope (Nikon A1). 
 
Pre-embed ImmunoTEM 
Cytospins were collected and processed as for immunofluorescence, except primary antibody dilutions 
were used at 1:50 and incubated overnight at 4oC and secondary antibodies were incubated at a dilution of 1:10 
at room temperature for 4 hours. Colloidal gold conjugated secondary antibodies used were goat anti-mouse 18 
nm and goat anti-rabbit 6 nm (Jackson ImmunoResearch). After the final wash, samples were fixed in 2.5% 
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glutaraldehyde in PBS for 1 hr. Monolayers were then washed in PBS three times then post-fixed in aqueous 
1% osmium tetroxide, 1% Fe6CN3 for 1 hr. Cells were washed 3 times in PBS then dehydrated through a 30-
100% ethanol series then several changes of Polybed 812 embedding resin (Polysciences, Warrington, PA). 
Cells were embedded by inverting Polybed 812-filled BEEM capsules on top of the cells.  Blocks were cured 
overnight at 37oC, then cured for two days at 65oC. Monolayers were pulled off the slides and ultrathin sections 
(60-70 nm) of the cells were obtained on a Leica EM UC7 ultramicrotome, post-stained in 4% uranyl acetate for 
10 min and 1% lead citrate for 7 min. Sections were viewed on a JEOL JEM 1400 transmission electron 
microscope (JEOL, Peobody MA) at 80 KV. Images were taken using a side-mount AMT 2k digital camera 
(Advanced Microscopy Techniques, Danvers, MA). 
 
RNAscope 
Tissue factor (F3), IL-6, and CD14 transcripts were localized to endotracheal aspirate cells by 
RNAscope Multiplex Fluorescent V2 assay (ACD) according to manufacturer instructions. Briefly, fixed-frozen 
cytospin sections were incubated with hydrogen peroxide and washed with distilled water. Then slides were 
placed in 1x target retrieval agent and antigen retrieval was performed at 99ºC for 5 minutes in a steamer, then 
slides were rinsed with distilled water, transferred to Ethanol 100% and dried overnight. The next day, slides 
were treated with Protease III and immediately treated for RNAscope. CD14 (C1, 520nm), Tissue Factor (C2, 
570nm) and IL-6 (C3, 690nm) probes were then hybridized, amplified and developed. Finally, slides were 
stained with DAPI and mounted with a ProLong Gold Antifade mountant, dried overnight at room temperature 
in the dark and stored at 4ºC until analysis. Slides were viewed and analyzed on a confocal scanning 
fluorescence microscope (Nikon A1). 
 
Quantitative Imaging Analysis 
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 Co-expression of Nucleocapsid protein with CD14, CD16, IL-6, and tissue factor was assessed using 
object-based area overlap analysis (NIS Elements, Nikon Inc., Melville NY). In brief, Z stacks were performed 
at Nyquist sampling. The data was deconvolved and binary masks for each channel were generated based on 
emission intensity. Co-expression was assessed using a binary “and” statement was used to determine pixels 
containing both Capsid protein “and” the marker of interest. Imaris (Bitplane) was used to generate a surface 
rendered image that illustrated the areas of co-localization in this dataset. 
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Supplemental Table 1: Additional description of antibodies 
Epitope Species Vendor Catalogue # IF Dilution EM Dilution 
SARS-CoV-2 
Nucleocapsid 
Rabbit Novus 
NB100-
56576 
5 µg/ml 10 µg /ml 
CD14 Mouse, Clone: MΦP9 BD Biosciences 347490 0.25 µg /ml 0.5 µg /ml 
CD16 Mouse, Clone DJ130c Invitrogen MA1-84008 1 µg /ml N/A 
CD142 (TF) Mouse, Clone HTF-1 BD Biosciences 550252 5 µg /ml N/A 
IL6 Rat Novus NBP2-44953 2 µg /ml N/A 
IgG Goat anti-Mouse 18 nm 
Jackson 
ImmunoResearch 
115-215-146 N/A 1:10 
IgG Goat anti-Rabbit 6 nm 
Jackson 
ImmunoResearch 
111-195-144 N/A 1:10 
IgG 
Goat-anti-mouse Alexa 
488 
Invitrogen A11029 2 µg /ml N/A 
IgG Goat anti-Rabbit Cy3 
Jackson 
ImmunoResearch 
111-165-003 2 µg /ml N/A 
 
Abbreviations: IF = immunofluorescence, EM = immuno-electron microscopy 
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